US2014170728A1PendingUtilityA1
Factor IX: Remodeling and Glycoconjugation of Factor IX
Est. expiryOct 10, 2021(expired)· nominal 20-yr term from priority
C12N 9/96C07K 14/505A61K 38/37C07K 1/13C07K 1/1077C07K 14/755C07K 9/00A61K 38/00C12N 9/644A61K 47/60A61P 9/00C07K 1/006
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.
Claims
exact text as granted — not AI-modified1 - 38 . (canceled)
39 . A covalent conjugate between a Factor IX peptide and a poly(ethylene glycol) that alters a property of said peptide, wherein said poly(ethylene glycol) is covalently attached to said Factor IX peptide at a preselected glycosyl or amino acid residue of said Factor IX peptide via an intact glycosyl linking group.
40 . (canceled)
41 . The covalent conjugate of claim 39 , wherein said poly(ethylene glycol) and an intact glycosyl linking group precursor are linked as a covalently attached unit to said Factor IX peptide via the action of an enzyme, said enzyme converting said precursor to said intact glycosyl linking group, thereby forming said conjugate.
42 . The covalent conjugate of claim 39 comprising:
a first poly(ethylene glycol) covalently linked to a first glycosyl residue of said Factor IX peptide via a first intact glycosyl linking group, and
a second poly(ethylene glycol) covalently linked to a second glycosyl residue of said Factor IX peptide via a second intact glycosyl linking group.
43 . The covalent conjugate of claim 42 , wherein said first glycosyl residue and said second glycosyl residue are structurally identical.
44 . The covalent conjugate of claim 42 , wherein said first glycosyl residue and said second glycosyl residue have different structures.
45 - 46 . (canceled)
47 . The covalent conjugate of claim 39 , wherein said Factor IX peptide is remodeled prior to forming said conjugate.
48 . The covalent conjugate of claim 47 , wherein the remodeled Factor IX peptide is remodeled to introduce an acceptor moiety for said intact glycosyl linking group.
49 - 51 . (canceled)
52 . The covalent conjugate of claim 39 , wherein said poly(ethylene glycol) has a molecular weight distribution that is essentially homodisperse.
53 - 112 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.